Predicting perinatal human immunodeficiency virus infection by antibody patterns

Area of Science:

• Immunology
• Virology
• Pediatrics

Background:

• Mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) remains a significant global health concern.
• Accurate and timely diagnosis of perinatal HIV-1 infection is crucial for initiating early treatment and improving outcomes.
• Standard diagnostic criteria often rely on prolonged observation periods, potentially delaying intervention.

Purpose of the Study:

• To investigate the longitudinal changes in HIV-1 antibody titers in infants born to HIV-1-seropositive mothers.
• To evaluate the utility of antibody decay patterns for early diagnosis of HIV-1 infection in infants.
• To assess the feasibility of using antibody decay for estimating vertical transmission rates.

Main Methods:

• Longitudinal study of 118 infants born to HIV-1-seropositive mothers in South Africa.
• Enzyme-linked immunosorbent assay (ELISA) used to determine HIV-1 antibody titers from birth to 18 months.
• Analysis of antibody decay rates in infected versus uninfected infants.

Main Results:

• By 18 months, 34.7% (41/118) of infants were diagnosed as HIV-1 infected.
• Uninfected infants (77) cleared maternal antibodies by 15 months, with 94.5% seroreverting by 12 months.
• A significant difference (P < 0.05) in antibody decay rates was observed by 9 months.
• Assessing antibody decay between 6 and 9 months showed high sensitivity (97.8%) and specificity (93.8%) for identifying uninfected infants.

Conclusions:

• Antibody decay rate analysis is a feasible and useful tool for diagnosing perinatal HIV-1 infection earlier than standard methods.
• This approach can aid in estimating vertical transmission rates more accurately.
• Monitoring antibody titer progression offers a promising strategy for early detection and management of HIV-1 in infants.